The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
Open accessAbstract
Background and Aims Although the incidence of hepatocellular carcinoma (HCC) is increasing in the United States, data from large prospective studies are limited. We evaluated the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) cohort for the incidence of HCC and associated risk factors. Methods HCV-positive patients with bridging fibrosis or cirrhosis that did not respond to peginterferon and ribavirin were randomized to groups that were given maintenance peginterferon for 3.5 years or no treatment. HCC incidence was determined by Kaplan-Meier analysis and baseline factors associated with HCC were analyzed by Cox regression. Results 1,005 patients (mean age 50.2 years, 71% male, 72% white) were studied; 59% had bridging fibrosis and 41% had cirrhosis. During a median follow-up of 4.6 years (maximum 6.7 years), HCC developed in 48 patients (4.8%). The cumulative 5-year HCC incidence was similar for peginterferon-treated patients and controls, 5.4% vs. 5.0% (p=0.78), and was higher among patients with cirrhosis than those with bridging fibrosis, 7.0% vs. 4.1% (p=0.08). HCC developed in eight (17%) patients whose serial biopsies showed only fibrosis. A multivariate analysis model comprising older age, black race, lower platelet count, higher alkaline phosphatase, esophageal varices, and smoking was developed to predict the risk of HCC. Conclusions We found that maintenance peginterferon did not reduce the incidence of HCC in the HALT-C cohort. Baseline clinical and laboratory features predicted risk for HCC. Additional studies are required to confirm our finding of HCC in patients with chronic hepatitis C and bridging fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406
Self-citationClinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Yoshida, H., Shiratori, Y., Moriyama, M., Arakawa, Y., Ide, T., Sata, M., Inoue, O., Yano, M., Tanaka, M., Fujiyama, S., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00003 · Cited by 1,096
The Natural History of Hepatitis C Virus (HCV) Infection
Chen, S. L., & Morgan, T. R. (2006) · International Journal of Medical Sciences · doi:10.7150/ijms.3.47 · Cited by 860
Self-citationNishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H., Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K., & Otani, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91739-x · Cited by 857
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El-Serag, H. B. (2005) · Gut · doi:10.1136/gut.2004.052167 · Cited by 704
Marrero, J. A., Fontana, R. J., Su, G. L., Conjeevaram, H. S., Emick, D. M., & Lok, A. S. (2002) · Hepatology · doi:10.1002/hep.1840360609 · Cited by 660
Self-citationVeldt, B. J., Heathcote, E. J., Wedemeyer, H., Reichen, J., Hofmann, W. P., Zeuzem, S., Manns, M. P., Hansen, B. E., Schalm, S. W., & Janssen, H. L. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-10-200711200-00003 · Cited by 602
Hepatitis C and hepatocellular carcinoma
Di Bisceglie, A. M. (1997) · Hepatology · doi:10.1002/hep.510260706 · Cited by 558
Self-citationCancer Incidence in Five Continents. Comparability and quality of data.
Dm, P., & Cs, M. (1992) · PubMed · Cited by 505
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El–Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.020 · Cited by 501
Benvegnù, L., Gios, M., Boccato, S., & Alberti, A. (2004) · Gut · doi:10.1136/gut.2003.020263 · Cited by 454
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
Velázquez, R. F., Rodríguez, M., Navascués, C. A., Linares, A., Pérez, R., Sotorríos, N. G., Martínez, I., & Rodrigo, L. (2003) · Hepatology · doi:10.1053/jhep.2003.50093 · Cited by 440
Environmental factors and risk for hepatocellular carcinoma
Yu, M. C., & Yuan, J.-M. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.018 · Cited by 426
Natural History of Hepatitis C
Thomas, D. L., & Seeff, L. B. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.05.003 · Cited by 402
Self-citationSimonetti, R. G., Cammà, C., Fiorello, F., Cottone, M., Rapicetta, M., Marino, L., Fiorentino, G., Craxì, A., Ciccaglione, A., Giuseppetti, R., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-2-97 · Cited by 354
Lok, A. S. F., Ghany, M. G., Goodman, Z. D., Wright, E. C., Everson, G. T., Sterling, R. K., Everhart, J. E., Lindsay, K. L., Bonkovsky, H. L., Di Bisceglie, A. M., et al. (2005) · Hepatology · doi:10.1002/hep.20772 · Cited by 344
Self-citationRelation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
Imai, Y., Kawata, S., Tamura, S., Yabuuchi, I., Noda, S., Inada, M., Maeda, Y., Shirai, Y., Fukuzaki, T., Kaji, I., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00005 · Cited by 338
Hepatocellular carcinoma: Recent trends in Japan
Kiyosawa, K., Umemura, T., Ichijo, T., Matsumoto, A., Yoshizawa, K., Gad, A., & Tanaka, E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.012 · Cited by 308
Hepatocellular carcinoma and hepatitis C in the United States
El-Serag, H. B. (2002) · Hepatology · doi:10.1002/hep.1840360710 · Cited by 291
Shiratori, Y., Ito, Y., Yokosuka, O., Imazeki, F., Nakata, R., Tanaka, N., Arakawa, Y., Hashimoto, E., Hirota, K., Yoshida, H., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-2-200501180-00009 · Cited by 282
Shiffman, M. L., Hofmann, C. M., Contos, M. J., Luketic, V. A., Sanyal, A. J., Sterling, R. K., Ferreira-Gonzalez, A., Mills, A. S., & Garret, C. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70402-6 · Cited by 254
Self-citationBralet, M.-P., Régimbeau, J.-M., Pineau, P., Dubois, S., Loas, G., Degos, F., Valla, D., Belghiti, J., Degott, C., & Terris, B. (2000) · Hepatology · doi:10.1053/jhep.2000.9033 · Cited by 249
Nzeako, U. C., Goodman, Z. D., & Ishak, K. G. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/105.1.65 · Cited by 229
Self-citationRaza, S. A., Clifford, G. M., & Franceschi, S. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603649 · Cited by 224
Ganne-Carrie, N., Chastang, C., Chapel, F., Munz, C., Pateron, D., Sibony, M., Deny, P., Trinchet, J., Callard, P., Guettier, C., et al. (1996) · Hepatology · doi:10.1002/hep.510230527 · Cited by 206
Lai, M., Hsieh, M., Chiu, Y., & Chen, T. H. (2006) · Hepatology · doi:10.1002/hep.21208 · Cited by 188
Pekow, J. R., Bhan, A. K., Zheng, H., & Chung, R. T. (2007) · Cancer · doi:10.1002/cncr.22701 · Cited by 185
Lee, W. M., Dienstag, J. L., Lindsay, K. L., Lok, A. S., Bonkovsky, H. L., Shiffman, M. L., Everson, G. T., Di Bisceglie, A. M., Morgan, T. R., Ghany, M. G., et al. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.08.003 · Cited by 167
Self-citationHepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy
Franceschi, S., Montella, M., Polesel, J., La Vecchia, C., Crispo, A., Dal Maso, L., Casarin, P., Izzo, F., Tommasi, L. G., Chemin, I., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0702 · Cited by 162
Lu, S., Wang, J., Liu, S., Hung, C., Chen, C., Tung, H., Chen, T., Huang, W., Lee, C., Chen, C., et al. (2006) · Cancer · doi:10.1002/cncr.22242 · Cited by 161
Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity
Seeff, L. B., & Hoofnagle, J. H. (2006) · Oncogene · doi:10.1038/sj.onc.1209560 · Cited by 155
Self-citationLiver Transplantation for Hepatocellular Carcinoma
Befeler, A. S., Hayashi, P. H., & Bisceglie, A. M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.033 · Cited by 132
Giannini, E. G., Risso, D., Testa, R., Trevisani, F., Nolfo, M. A. D., Poggio, P. D., Benvegnù, L., Rapaccini, G. L., Farinati, F., Zoli, M., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.08.011 · Cited by 93
Bège, T., Treut, Y. P. L., Hardwigsen, J., Ananian, P., Richa, H., Campan, P., & Garcia, S. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-006-0023-9 · Cited by 66
for the JACC Study Group, Fujita, Y., Shibata, A., Ogimoto, I., Kurozawa, Y., Nose, T., Yoshimura, T., Suzuki, H., Iwai, N., Sakata, R., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602981 · Cited by 59
Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C
Kumar, D., Farrell, G. C., Kench, J. G., & George, J. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04007.x · Cited by 54
The natural history of hepatitis C with severe hepatic fibrosis
Lawson, A., Hagan, S., Rye, K., Taguri, N., Ratib, S., Zaitoun, A. M., Neal, K. R., Ryder, S. D., & Irving, W. L. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.010 · Cited by 53
Prevention of Hepatocellular Carcinoma
Craxı̀, A., & Cammà, C. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.008 · Cited by 50
Bonis, P. A., Tong, M. J., Blatt, L. M., Conrad, A., & Griffith, J. L. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00207-5 · Cited by 38
SAID, A., Williams, J., Holden, J., Remington, P., MUSAT, A., & Lucey, M. R. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00393-3 · Cited by 26
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“A recent study from the United States has pointed out that HCC does occur in patients with chronic hepatitis C and bridging fibrosis in the absence of cirrhosis (Metavir F3) [12].”
BackgroundVillanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
Metadata
- Authors
- Lok, A. S., Seeff, L. B., Morgan, T. R., di Bisceglie, A. M., Sterling, R. K., Curto, T. M., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., Dienstag, J. L., Ghany, M. G., Morishima, C., & Goodman, Z. D.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 136
- Issue
- 1
- Pages
- 138-148
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2168076454
- Cited by
- 651
- References
- 45
- FWCI
- 24.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.